openPR Logo
Press release

Allergic Rhinitis Market 2018 by Seasonal, Perennial and Non-Allergic Rhinitis Type & Forecasts Till 2026

12-30-2019 08:32 AM CET | Health & Medicine

Press release from: Optima insights Pvt Ltd

Allergic Rhinitis Treatment Market

Allergic Rhinitis Treatment Market

The Allergic Rhinitis Treatment Market was valued at US $6.95 billion in the year 2018 and is estimated to reach US $9.66 billion by 2026, at a CAGR of 4.20%.
Allergic Rhinitis is inflammation caused inside the nose by allergen, also called as hay fever. Allergic Rhinitis develops when body’s immune system becomes sensitized and overreacts on exposure to allergens in the environment. It is mostly triggered by outdoor allergens like pollens from grass, trees, weeds, Indoor allergens like dust mite, animal dander, mold and irritants such as cigarette smoke, perfume, wood smoke, fumes, cold temperatures, chemicals, pollution and diesel exhaust. Symptoms of Allergic Rhinitis include runny, stuffy & itchy nose, sneezing, coughing, itchy & watery eyes, dark circles under eyes, frequent headaches, hives and excess fatigue.
There are two types of allergic rhinitis, seasonal and perennial. Seasonal allergic rhinitis is observed during the spring and fall season due to outdoor allergens like pollen while perennial allergic rhinitis can be seen year-round at any time due to dust mite. The class of drugs for the treatment of Allergic Rhinitis include Antihistamines, Corticosteroids, Decongestants, Immunotherapy and Intranasal Anticholinergics. Immunotherapy includes subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT). Allergic Rhinitis causes nasal membranes swelling in turn causes sinusitis and may also be associated with nasal polyps, small, non-cancerous growths and nosebleeds.
Allergic Rhinitis affects 10-30% of global population. According to World Allergy Organization, over 400 million people suffer from allergic rhinitis worldwide. Over 7.8% of people over 18 years of age and around 50 million people in the U.S. suffer from allergic rhinitis according to American Academy of Allergy, Asthma & Immunology. Allergy is the 6th leading cause of chronic illness in the U.S. According to European Community Respiratory Health survey there is prevalence of 10 to 41% in adults with allergic rhinitis. Severe allergic rhinitis symptoms in children are observed to be high in Africa and Latin America.
The major challenge of treating allergic rhinitis is its unknown pathogenesis and increasing competition from generics. Allergic rhinitis market is expected to grow in the U.S. due to an increase in the incidence of allergies and hay fever cases (19.2 million around 7.7 % of population in 2018). Emerging market trends are observed in Asian Pacific regions such as India, China, and South Korea due to increased levels of air pollution. Among the treatment regimens, immunotherapy treatment segment will be fastest growing over forecast period.
The major market driver for Allergic Rhinitis treatment is the increase in prevalence and increasing awareness of allergic rhinitis symptoms. Perennial Allergic Rhinitis cases are increasing more globally which needs continuous medications till the symptoms subside and might positively impact the market growth. The major market restraint was high cost of immunotherapy treatments and long duration of treatment for Allergic Rhinitis. Development of cost-effective advanced treatments might gain more attention in the global market in the forecast period.
Major companies for the treatment of Allergic Rhinitis Treatment include Alcon Inc, Merck & Co. Inc., Fountain Biopharma, Sumitomo Pharma co, Genentech, Inc., Pfizer, Inc., Hanmi Pharmaceuticals, Sanofi, Glenmark Pharmaceutical, Ampio Pharmaceutical Inc., Hisamitsu Pharmaceutical Co., Johnson & Johnson and Teva Pharmaceutical Ltd. According to clinicaltrials.gov, there are around 17 active interventional trials for the treatment of Allergic Rhinitis Treatment at present.
Recent Updates
• Ragweed sublingual immunotherapy (SLIT) improved symptoms in children with Ragweed Allergic Rhinitis
• Benralizumab Improved Total Nasal Symptom Score in Severe Asthma Allergic Rhinitis
• GSK recently announced intranasal steroid Fluticasone furoate spray for treatment of allergic rhinitis
Allergic Rhinitis Treatment Market Based on Treatment Class (Market Size and Forecast, and Y-o-Y Growth, (US$ Mn):
• Antihistamines
• Corticosteroids
• Decongestants
• Immunotherapy
• Intranasal Anticholinergics
Allergic Rhinitis Treatment Market Based on Geographic Region (Market Size and Forecast, and Y-o-Y Growth, (US$ Mn)
• North America
• Europe
• APAC
• LAMEA

Research Scope
• Provides a detailed Analysis of the Market Structure along with forecast of the various segments and sub-segments.
• Provides a Comparative Analysis of Key Marketed and Pipeline Products.
• Provides Key Information on Players involved.
• Provides a Complete Overview of Market Segments and the Regional Outlook.
• Provides In-depth Coverage of Key News, including Major Mergers, Acquisitions and Product Development updates such as clinical trial progression updates and regulatory updates.

The Report Provides Key Insights on
• History of the Allergic Rhinitis Treatment Market, 2015 to 2017
• Forecast of the Allergic Rhinitis Treatment Market Growth till the year 2026
• The key market drivers, restraints, challenges, future opportunities and the market dynamics driving the Allergic Rhinitis Treatment Market
• Analysis of potential growth segments which will drive the market
• Landscape analysis of the major companies, and new market entrants and companies which possess disruptive technologies which can change the trend of the entire market
• Key market approaches adopted by the organizations and in-depth intelligence of potential strategies which could alter the market dynamics

Optima Insights
Mr Chucks G
+91 966 6620 365 (Asia) | +1 424 2554 365 (US)
Email: sales@optimainsights.org
https://www.optimainsights.org
# 206, City Tower Complex, Kothapet, Hyderabad - 35 Telangana, I N D I A.

Optima Insights is an innovative research and insights-driven enterprise committed to offering actionable intelligence to the global life science and healthcare market. We believe that meaningful insights and improved strategic content hold the key to improved ROI for our clients. We strike an innovative engagement model with our clients to Co-Create Intelligence that would address very specific issues facing them within their functional areas. We continuously support clients through the entire journey map to enable them to make better business decisions towards attaining market leadership.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Allergic Rhinitis Market 2018 by Seasonal, Perennial and Non-Allergic Rhinitis Type & Forecasts Till 2026 here

News-ID: 1887127 • Views:

More Releases from Optima insights Pvt Ltd

Endometriosis Treatment Market is Expected to Reach $3.43 bn by 2027
The Endometriosis Treatment Market was valued at US $2.64 billion in the year 2019 and is estimated to reach US $3.43 billion by 2027, at a CAGR of 3.36%. The growth of tissue outside the uterus similar to lining of uterus (endometrium) refers to Endometriosis. Areas of endometrial tissue growth often occur in ovaries, fallopian tubes, peritoneum and outer surfaces of bladder, uterus, intestines, and rectum and rarely spread beyond pelvic
Inflammatory Bowel Disease (IBD) Treatment Market is Expected to Reach $15.5 bn …
The Inflammatory Bowel Disease (IBD) treatment market share was US$ 11.38 Bn in the year 2018. The market is anticipated to grow at a rate of 3.94%, through the forecast period to reach US$ 15.5 Bn by the year 2027. Inflammatory Bowel Disease (IBD) usually denotes disorders characterized by the inflammation in the digestive system. Inflammatory Bowel Disease (IBD) and Irritable Bowel Syndrome are two different disorders that are often confused
Polycystic Ovarian Syndrome (PCOS) Treatment Market is Expected to Reach $5.59 b …
The Polycystic Ovarian Syndrome (PCOS) Treatment Market was valued at US $3.74 billion in the year 2019 and is estimated to reach US $5.59 billion by 2027, at a CAGR of 5.18%. Polycystic Ovarian Syndrome (PCOS), also referred to as Stein-Leventhal syndrome is a hormonal disorder characterized by enlarged ovaries and formation of numerous small cysts (fluid-filled sacs) on the outer edges of the ovaries. Symptoms of PCOS include irregular periods,
Veterinary Vaccines Market is Expected to Reach $13.51 bn by 2027
The Veterinary Vaccines Market was valued at US $7.91 billion in the year 2018 and is estimated to reach US $13.51 billion by 2027, at a CAGR of 6.13%. Generally, vaccines are effective in preventing infectious diseases. Veterinary vaccines especially reduce the burden of the disease in animals and also helps in preventing several zoonotic diseases also. There are four types of veterinary vaccines available depending on preparation type, they are

All 5 Releases


More Releases for Allergic

Prominent Allergic Rhinitis Market Trend for 2025: Advancements In Treating Nasa …
Which drivers are expected to have the greatest impact on the over the allergic rhinitis market's growth? Anticipated growth in the allergic rhinitis market is predicted to be driven by increasing levels of air pollution and the impact of climate change. The term air pollution denotes the existence of harmful substances in our planet's atmosphere, which can negatively impact human health, damage the environment, and reduce the air's quality. Climate change
Allergic Rhinitis: A Comprehensive Overview
Allergic rhinitis, commonly known as hay fever, is a condition where an individual's immune system overreacts to allergens in the air. These allergens, which may include pollen, dust, or pet dander, trigger inflammation inside the nose, leading to symptoms like sneezing, a runny nose, itchy eyes, and congestion. While often associated with the spring and fall seasons due to pollen levels, allergic rhinitis can affect individuals year-round, depending on the
Allergic Conjunctivitis Market Statistics, Growth | Forecast
The new report published by The Business Research Company, titled ""Allergy Conjunctivitis Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends. As per the report, the allergy conjunctivitis market size has grown strongly in recent years. It will grow from $2.4 billion in 2023
Anti-Allergic Drugs Market Overview 2030
Anti-allergic drugs represent a pivotal domain in healthcare, providing advanced solutions to alleviate symptoms triggered by allergens. With an ever-growing prevalence of allergies globally, the anti-allergic drugs market is witnessing a significant surge. Valued at USD 26,234 Million in 2021, the market is poised to skyrocket to USD 47,566 Million by 2030, showcasing a robust CAGR of 6.8%. In the United States alone, where allergies affect 40 to 50 million
Allergic Conjunctivitis Market - Clear Eyes, Allergy-Free: Allergic Conjunctivit …
Newark, New Castle, USA: The "Allergic Conjunctivitis Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Allergic Conjunctivitis Market: https://www.growthplusreports.com/report/allergic-conjunctivitis-market/7892 This latest report researches the industry structure, sales, revenue,
Allergic Conjunctivitis Market - Empowering Eyes, Enhancing Lives: Redefining Al …
Newark, New Castle, USA - new report, titled Allergic Conjunctivitis Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Allergic Conjunctivitis market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Allergic Conjunctivitis market. The report offers an overview of the market, which